WO2014116000A1 - Method for producing collagen scaffold coated with apatite - Google Patents

Method for producing collagen scaffold coated with apatite Download PDF

Info

Publication number
WO2014116000A1
WO2014116000A1 PCT/KR2014/000546 KR2014000546W WO2014116000A1 WO 2014116000 A1 WO2014116000 A1 WO 2014116000A1 KR 2014000546 W KR2014000546 W KR 2014000546W WO 2014116000 A1 WO2014116000 A1 WO 2014116000A1
Authority
WO
WIPO (PCT)
Prior art keywords
apatite
mimetic
support
collagen
coated
Prior art date
Application number
PCT/KR2014/000546
Other languages
French (fr)
Korean (ko)
Inventor
김병수
노승서
강서경
Original Assignee
서울대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서울대학교산학협력단 filed Critical 서울대학교산학협력단
Publication of WO2014116000A1 publication Critical patent/WO2014116000A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/32Phosphorus-containing materials, e.g. apatite

Definitions

  • the present invention relates to a method for producing a medical support, more specifically, a collagen support coated with apatite having excellent bone regeneration effect.
  • Bones are composed of bone tissue, which serves to support and protect the organs of the body. What constitutes bone tissue is bone tissue (osseous tissue), which constitutes the rigid part of the bone organs and forms the skeletal system and thus is classified as an important supportive connective tissue of the body.
  • bone tissue osseous tissue
  • Such bone tissue is an organic / inorganic hybrid biocomposite material composed of various organic components such as proteins and cells and inorganic components such as apatite.
  • apatite hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 ), a calcium phosphate (CaP) crystal, that is spatially arranged between collagen fibrils. It comes from a hierarchical structure.
  • cracking or splitting of bones may occur due to physical trauma, or may be caused by certain medical conditions that weaken bones such as osteoporosis.
  • Synthetic biomaterials such as artificial bones, are used to heal fractures or damaged bones, and various methods have been tried to further improve the biocompatibility of such synthetic biomass.
  • the problem to be solved by the present invention is to provide a method for more efficiently producing a medical support having excellent bone regeneration efficacy.
  • a mimetic fluid comprising at least one salt of hydrochloride, carbonate, phosphate and sulfate;
  • It provides a method for producing an apatite-coated collagen support comprising a; immersing a collagen support in the mimetic fluid to coat apatite on the surface of the support.
  • the salt may be used at least one of NaCl, NaHCO 3 , KCl, K 2 HPO 4 , MgCl 2 , CaCl 2 , and Na 2 SO 4 .
  • the mimetic fluid may have a concentration of 1 to 20 times based on the concentration of the body fluid.
  • the pH of the mimetic liquid may have a range of 8 to 11.
  • the apatite may include hydroxyapitite.
  • a collagen sponge may be used as the collagen support.
  • the mimetic liquid in the coating step may have a temperature range of about 15 to about 35 °C.
  • the mimetic liquid in the coating step may have a temperature range of about 15 to about 25 °C.
  • the present invention provides a method for efficiently coating the collagen support with an apatite, an inorganic component of bone at an optimal pH. According to this method, it becomes possible to coat more content of apatite on the collagen support more simply and efficiently within a shorter time. In particular, when using the mimetic liquid having a predetermined temperature range within the optimum pH range, the coating content of the apatite can be maximized.
  • the support for bone regeneration obtained by the above method exhibits excellent biocompatibility and bone conductivity, and can release bone morphogenetic protein, a growth factor protein that promotes bone regeneration, in a sustained release manner, thereby treating bone-related diseases. It can be effectively used as a carrier for a medical implant or bone forming protein for bone regeneration.
  • 1 is a schematic diagram schematically showing a coating process according to the pH change of the mimetic fluid.
  • Figure 2 is a graph showing the result of quantitatively comparing the amount of apatite coated on the surface of the collagen support according to the pH and temperature change according to the Examples and Comparative Examples, respectively.
  • Figure 3 shows a SEM photograph of the apatite coated on the collagen support surface as the pH is changed in the mimetic fluid of 20.
  • a method of preparing an apatite-coated collagen support includes preparing a mimetic fluid including at least one salt of hydrochloride, carbonate, phosphate and sulfate; Adjusting the pH of the mimetic solution to 8 to 13; And coating an apatite on the surface of the support by immersing the collagen support in the mimetic fluid.
  • the manufacturing method provides a method for efficiently coating the collagen support with the apatite, which is an inorganic component of bone, using a mimetic fluid having optimal conditions, for example, a predetermined pH range and / or a predetermined temperature range.
  • FIG. 1 A schematic diagram schematically showing the change in the distribution of metal ions on the collagen support surface as the pH of the mimetic fluid changes is shown in FIG. 1.
  • the method for preparing collagen support of the present invention essentially includes adjusting the pH of the simulated solution in which various salts are dissolved to 8 or more, which is the isoelectric point of the collagen support, and the pH of collagen isoelectric point (PI) as shown in FIG. 1.
  • the pH of the mimetic fluid is lower than the isoelectric point, for example, pH 6 or less, the surface of the collagen becomes positively charged, which makes it difficult to adsorb calcium ions, the main component of apatite, to the surface of the collagen.
  • the coating content of apatite is reduced.
  • a collagen sponge may be used as the collagen support.
  • any structure having a cavity or void in collagen can be used without particular limitation.
  • a collagen solution or a dispersion prepared by lyophilization can be used. There is no particular limitation on the lyophilization method.
  • the collagen is not dissolved in the mimetic fluid, so that it is necessary to crosslink or insolubilize if necessary.
  • physical and / or chemical crosslinking may be used as an example of the crosslinking
  • UV treatment or the like may be used as such a physical crosslinking process
  • aldehydes such as glutaraldehyde, formalin, and dialdehyde starch may be used as the chemical crosslinking process.
  • Crosslinking process using a compound, water-soluble polyepoxy compounds, such as polyethyleneglycol diglycidyl ether, and isocyanate compounds, such as hexamethylene diisocyanate, etc. can be used.
  • the crosslinking agent and the crosslinked product may be one which is not cytotoxic and excellent in biocompatibility.
  • the surface of the collagen support is coated with apatite, the main component of calcium and phosphorus dissolved in the mimetic fluid.
  • the surface may include the surface of the cavity and / or voids present in the support, in addition to the surface of the collagen support, eg, all and / or a portion of the collagen sponge.
  • the apatite may be coated on the entire surface, or may be partially coated on the surface.
  • a coating means is not specifically limited, The method of immersing a collagen support body in a mimic liquid can be illustrated.
  • the mimetic liquid may be a solution containing one or more salts in water, for example distilled water or deionized water, and one or more of hydrochloride, carbonate, phosphate and sulfate may be used as such salts.
  • these salts may include alkali metals and / or alkaline earth metals as metal ions. Examples of the alkali metal include sodium, potassium, and the like, and magnesium, calcium, and the like may be used as the alkaline earth metal.
  • the hydrochloride may exemplify a compound in which an alkali metal or alkaline earth metal is combined with chlorine, and for example, NaCl, KCl, MgCl 2 , CaCl 2 , and the like may be used.
  • the carbonate is a secondary carbonate in which all of the hydrogen of carbonic acid (H 2 CO 3 ) is substituted with an alkali metal or alkaline earth metal, or a primary carbonate (bicarbonate) in which one hydrogen of carbonate is substituted with an alkali metal Can be used.
  • the phosphate includes a primary phosphate (dihydrogen phosphate) in which one hydrogen of phosphoric acid (H 3 PO 4 ) is substituted, and a secondary phosphate (hydrogen phosphate) in which two hydrogens of phosphoric acid are substituted.
  • a tertiary phosphate in which hydrogen of phosphoric acid is three substituted may be exemplified, and examples of the metal which may be substituted may include an alkali metal or an alkaline earth metal. Examples of these phosphates and the like can be given K 2 HPO 4, Na 2 HPO 4, CaHPO 4, MgHPO 4, NaH 2 PO 4, KH 2 PO 4.
  • the sulfate is a primary sulfate (bisulfate) in which hydrogen of sulfuric acid (H 2 SO 4 ) is substituted with an alkali metal
  • secondary hydrogen in which all of the hydrogen of the sulfuric acid is substituted with an alkali metal or alkaline earth metal sulfate and the like
  • the mimetic fluid may include at least one of NaCl, NaHCO 3 , KCl, K 2 HPO 4 , MgCl 2 , CaCl 2 and Na 2 SO 4 as a salt component, for example NaCl, One or more of NaHCO 3 , K 2 HPO 4 , and CaCl 2 .
  • these salt components can be dissolved in water, for example distilled water or deionized water, and used to form a simulated body fluid, wherein the salt concentration of the simulated body fluid is of a normal healthy body, for example, a healthy human body or an animal body. It may have a range of 1 to 20 times, for example 1 to 15 times, or 1 to 10 times based on the body fluid concentration. As the concentration of the mimetic fluid is higher, the coating content of the coated apatite increases, and the coating time may also decrease.
  • water for example distilled water or deionized water
  • the collagen support is immersed in the mimetic extract as described above to coat the apatite component on the surface of the support.
  • the immersion process is performed for 1 hour or more, for example 5 hours. It can be carried out for more than one day, or more than one day to less than 10 days, the longer the immersion time is able to coat a large amount of apatite, but if the immersion time is too long there is a risk of collagen degeneration is caused. .
  • a sufficient amount of apatite coating can be achieved in a shorter time at the same concentration of the mimetic liquid.
  • Such a short time coating has an advantage of minimizing collagen denaturation.
  • the apatite coating content may vary depending on the temperature of the mimetic solution in which the immersion process is performed, and the temperature of the mimetic solution in which the collagen support is immersed is, for example, 15 to 35 ° C, or 15 to 15. A range of 25 ° C. can be used.
  • the coating time can be shortened as the temperature of the mimetic fluid increases, but it is preferable to control the collagen in a predetermined range since there is a risk of degeneration of collagen.
  • Collagen support coated with apatite for example, hydroxyapatite according to the present invention is efficiently prepared in a short time in a predetermined pH range, modified to have a bone regeneration effect such as excellent biocompatibility, cell compatibility and osteoconductivity (osteoconductivity) It can be usefully used as a medical implant.
  • apatite for example, hydroxyapatite according to the present invention is efficiently prepared in a short time in a predetermined pH range, modified to have a bone regeneration effect such as excellent biocompatibility, cell compatibility and osteoconductivity (osteoconductivity) It can be usefully used as a medical implant.
  • a collagen sponge composed of bovine-derived collagen type 1 was prepared as a support.
  • NaCl (8.0035 g / L), NaHCO 3 (0.355 g / L), KCl (0.225 g / L), K 2 HPO 42 O (0.231 g / L), CaCl 2 (0.292 g / L), Na 2 SO 4 (0.072 g / L), and MgCl 22 O (0.311 g / L) were dissolved in distilled water to prepare a mimic liquid.
  • pH 4 NaOH or HCl was added to the mimetic liquid
  • the pH range was set to pH 4, 5, 6, 7, 8, 9, 10, 11.
  • pH 4, 5, 6, 7 is a comparative example, and pH 8, 9, 10, 11 is an Example.
  • the collagen support was immersed in each of the mimetic fluids at different temperature conditions of 4 ° C., 20 ° C. and 40 ° C. for 24 hours to obtain a collagen support coated with hydroxyapatite.
  • the collagen support without any treatment was prepared for comparison.
  • the hydroxyapatite coating content of the collagen support treated by changing the pH of the mimetic fluid from 4 to 11 at 4 ° C., 20 ° C. and 40 ° C. temperature is shown in FIG. 2.
  • the coating content is a value indicated by calculating the amount of calcium in the mass increase after measuring the change in the content of the collagen support before and after coating.
  • FIG. 3 is an SEM image showing the degree of coating of hydroxyapatite coated on the collagen surface at 20 ° C. simulated liquid.
  • the present invention provides a method for efficiently coating the collagen support with an apatite, an inorganic component of bone at an optimal pH. According to this method, it becomes possible to coat more content of apatite on the collagen support more simply and efficiently within a shorter time. In particular, when using the mimetic liquid having a predetermined temperature range within the optimum pH range, the coating content of the apatite can be maximized.
  • the support for bone regeneration obtained by the above method exhibits excellent biocompatibility and bone conductivity, and can release bone morphogenetic protein, a growth factor protein that promotes bone regeneration, in a sustained release manner, thereby treating bone-related diseases. It can be effectively used as a carrier for a medical implant or bone forming protein for bone regeneration.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The present invention relates to a method for producing a collagen scaffold coated with apatite by processing a surface of the collagen scaffold with a simulated body fluid of pH 8-13. The collagen scaffold coated by apatite, according to the present invention, is effectively produced in a short period of time and is modified so as to have osteanagenesis effects including excellent biocompatibility, cell compatibility, osteoconductive properties, and osteogenic protein sustained-release properties, and is thus useful as a medical graft material.

Description

아파타이트가 코팅된 콜라겐 지지체의 제조방법Method for preparing collagen support coated with apatite
본 발명은 우수한 골 재생효능을 갖는 의료용 지지체, 보다 상세하게는 아파타이트로 코팅된 콜라겐 지지체의 제조방법에 관한 것이다.The present invention relates to a method for producing a medical support, more specifically, a collagen support coated with apatite having excellent bone regeneration effect.
뼈는 뼈 조직(bone tissue)으로 구성되어 있고, 신체의 장기를 지지하고 보호하는 역할을 한다. 뼈 조직을 구성하는 것은 골 조직(osseous tissue)이며 이는 뼈 기관의 강직한 부분을 구성하여 골격계를 이루기 때문에 신체의 중요한 지지적 결합 조직으로 분류된다.Bones are composed of bone tissue, which serves to support and protect the organs of the body. What constitutes bone tissue is bone tissue (osseous tissue), which constitutes the rigid part of the bone organs and forms the skeletal system and thus is classified as an important supportive connective tissue of the body.
이와 같은 뼈 조직은 단백질 및 세포 등과 같은 다양한 유기 성분과 아파타이트 등의 무기 성분으로 이루어진 유기/무기 하이브리드(hybrid) 생복합체 물질이다. 예를 들어 천연 상태의 뼈가 갖는 중요한 화학적 및 기계적 물성은 칼슘 포스페이트(CaP) 결정인 히드록시아파타이트 [Ca10(PO4)6(OH)2]가 형성되어 콜라겐 피브릴 사이에 공간적으로 배열되는 계층적 구조로부터 유래한다.Such bone tissue is an organic / inorganic hybrid biocomposite material composed of various organic components such as proteins and cells and inorganic components such as apatite. For example, the important chemical and mechanical properties of natural bones include the formation of hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 ), a calcium phosphate (CaP) crystal, that is spatially arranged between collagen fibrils. It comes from a hierarchical structure.
일반적으로 뼈의 균열 또는 분열은 신체적 외상으로 인해 발생할 수 있으며, 그 외에 골다공증과 같은 뼈를 약화시키는 특정한 의료적 질환 등으로 인해 생길 수도 있다. 골절 또는 손상된 뼈를 치유하기 위해 인공뼈와 같은 합성 생물질이 사용되는데, 이러한 합성 생물질의 생체 적합성을 보다 개선하기 위한 다양한 방법들이 시도되어 왔다.In general, cracking or splitting of bones may occur due to physical trauma, or may be caused by certain medical conditions that weaken bones such as osteoporosis. Synthetic biomaterials, such as artificial bones, are used to heal fractures or damaged bones, and various methods have been tried to further improve the biocompatibility of such synthetic biomass.
구체적인 예로서, 플라즈마 분사법을 이용하여 타겟 재료의 표면에 생체적합성 칼슘 포스페이트 박막을 코팅하는 방법이 알려져 있다 (참조: J. Biomed. Mater. Res. 48, 741 (1999)). 그러나 이 방법에 의하면 재료의 안쪽 표면에 균일하게 칼슘 포스페이트 박막을 코팅하기 어렵고, 플라즈마 방출시 고분자 지지체가 고온에 노출되어 변형될 수 있다는 단점이 존재한다.As a specific example, a method of coating a biocompatible calcium phosphate thin film on the surface of a target material by using plasma spraying is known (J. Biomed. Mater. Res. 48, 741 (1999)). However, this method has a disadvantage in that it is difficult to uniformly coat a thin film of calcium phosphate on the inner surface of the material, and that the polymer support may be deformed by being exposed to high temperature during plasma emission.
한편, 지지체를 pH 7의 모사체액 (simulated body fluid: SBF)에 침지하여 상기 지지체의 표면에 칼슘과 인이 주요 성분인 아파타이트 결정을 코팅하는 방법이 다양한 문헌에 알려져 있다 (참조: J. Biomed. Mater. Res. 24, 721 (1990); Tissue Eng Part A. 17 (17-18):2153-64 (2011); J. Biomater. Sci. 23 1659-1671 (2012)). 또한 일본특허출원공개 제2004-275533호에도 pH 6 또는 7의 모사체액에 지지체를 침지하여 상기 지지체의 표면에 아파타이트를 코팅하는 방법이 개시되어 있다. 하지만 상기 방법들에 의하면, 충분한 함량으로 아파타이트를 표면 코팅하는 공정에 상당한 시간이 소요되어 경제성이 저하된다는 문제가 있다.On the other hand, various documents are known in the literature to immerse a support body in a simulated body fluid (SBF) of pH 7 to coat the surface of the support with apatite crystals, the main component of calcium and phosphorus (see J. Biomed. Mater. Res. 24, 721 (1990); Tissue Eng Part A. 17 (17-18): 2153-64 (2011); J. Biomater. Sci. 23 1659-1671 (2012)). Japanese Patent Application Laid-Open No. 2004-275533 also discloses a method of coating an apatite on the surface of the support by immersing the support in a simulated solution of pH 6 or 7. However, according to the above methods, there is a problem in that the process of surface coating the apatite with a sufficient content takes a considerable time, thereby lowering economic efficiency.
따라서 다양한 의료용 이식재의 필요성이 점점 커짐에 따라, 더욱 우수한 골 재생효능을 갖는 지지체를 보다 효율적으로 제조할 수 있는 기술에 대한 개발이 필요하다.Therefore, as the necessity of various medical implants increases, there is a need for a technology for more efficiently manufacturing a support having a superior bone regeneration effect.
본 발명이 해결하고자 하는 과제는, 우수한 골 재생 효능을 갖는 의료용 지지체를 보다 효율적으로 제조할 수 있는 방법을 제공하는 것이다.The problem to be solved by the present invention is to provide a method for more efficiently producing a medical support having excellent bone regeneration efficacy.
상기 과제를 달성하기 위하여 본 발명은,In order to achieve the above object, the present invention,
염산염, 탄산염, 인산염 및 황산염 중 1종 이상의 염을 포함하는 모사체액을 준비하는 단계;Preparing a mimetic fluid comprising at least one salt of hydrochloride, carbonate, phosphate and sulfate;
상기 모사체액의 pH를 8 내지 13으로 조절하는 단계; 및Adjusting the pH of the mimetic solution to 8 to 13; And
콜라겐 지지체를 상기 모사체액에 침지하여 상기 지지체의 표면에 아파타이트를 코팅하는 단계;를 포함하는 아파타이트가 코팅된 콜라겐 지지체의 제조방법을 제공한다.It provides a method for producing an apatite-coated collagen support comprising a; immersing a collagen support in the mimetic fluid to coat apatite on the surface of the support.
일구현예에 따르면, 상기 염은 NaCl, NaHCO3, KCl, K2HPO4, MgCl2, CaCl2, 및 Na2SO4 중 1종 이상을 사용할 수 있다.According to one embodiment, the salt may be used at least one of NaCl, NaHCO 3 , KCl, K 2 HPO 4 , MgCl 2 , CaCl 2 , and Na 2 SO 4 .
일구현예에 따르면, 상기 모사체액은 체액의 농도를 기준으로 1배 내지 20배의 농도를 가질 수 있다.According to one embodiment, the mimetic fluid may have a concentration of 1 to 20 times based on the concentration of the body fluid.
일구현예에 따르면, 상기 모사체액의 pH는 8 내지 11의 범위를 가질 수 있다.According to one embodiment, the pH of the mimetic liquid may have a range of 8 to 11.
일구현예에 따르면, 상기 아파타이트는 히드록시아파이트를 예로 들 수 있다.According to one embodiment, the apatite may include hydroxyapitite.
일구현예에 따르면, 상기 콜라겐 지지체로서는 콜라겐 스펀지를 사용할 수 있다.According to one embodiment, a collagen sponge may be used as the collagen support.
일구현예에 따르면, 상기 코팅 단계에서 상기 모사체액은 약 15 내지 약 35℃의 온도 범위를 가질 수 있다.According to one embodiment, the mimetic liquid in the coating step may have a temperature range of about 15 to about 35 ℃.
일구현예에 따르면, 상기 코팅 단계에서 상기 모사체액은 약 15 내지 약 25℃의 온도 범위를 가질 수 있다.According to one embodiment, the mimetic liquid in the coating step may have a temperature range of about 15 to about 25 ℃.
본 발명은 최적의 pH에서 골의 무기 성분인 아파타이트를 콜라겐 지지체에 효율적으로 코팅시킬 수 있는 방법을 제공한다. 상기 방법에 따르면, 보다 짧은 시간 내에 보다 많은 함량의 아파타이트를 콜라겐 지지체 상에 보다 간편하게 효율적으로 코팅하는 것이 가능해진다. 특히 상기 최적의 pH 범위 내에서, 소정 온도 범위를 갖는 모사체액을 사용하는 경우, 상기 아파타이트의 코팅 함량은 극대화될 수 있다.The present invention provides a method for efficiently coating the collagen support with an apatite, an inorganic component of bone at an optimal pH. According to this method, it becomes possible to coat more content of apatite on the collagen support more simply and efficiently within a shorter time. In particular, when using the mimetic liquid having a predetermined temperature range within the optimum pH range, the coating content of the apatite can be maximized.
상기 방법에 의해 얻어지는 골 재생용 지지체는 우수한 생체적합성과 골전도성을 나타내고, 골 재생을 촉진시키는 성장인자 단백질인 골형성 단백질(bone morphogenetic protein)을 서방형으로 방출시킬 수 있으므로, 골 관련 질환을 치료하기 위한 의료용 이식재 또는 골 재생용 골형성단백질의 전달체로 효과적으로 사용될 수 있게 된다.The support for bone regeneration obtained by the above method exhibits excellent biocompatibility and bone conductivity, and can release bone morphogenetic protein, a growth factor protein that promotes bone regeneration, in a sustained release manner, thereby treating bone-related diseases. It can be effectively used as a carrier for a medical implant or bone forming protein for bone regeneration.
도 1은 모사체액의 pH 변화에 따른 코팅 공정을 개괄적으로 나타낸 모식도이다.1 is a schematic diagram schematically showing a coating process according to the pH change of the mimetic fluid.
도 2는 실시예 및 비교예에 따라 각각 pH와 온도 변화에 따른 콜라겐 지지체 표면에 코팅된 아파타이트의 양을 정량적으로 비교한 결과를 나타내는 그래프이다.Figure 2 is a graph showing the result of quantitatively comparing the amount of apatite coated on the surface of the collagen support according to the pH and temperature change according to the Examples and Comparative Examples, respectively.
도 3은 20의 모사체액에서 pH를 변화시킴에 따라 콜라겐 지지체 표면에 코팅된 아파타이트를 촬영한 SEM 사진을 나타낸다.Figure 3 shows a SEM photograph of the apatite coated on the collagen support surface as the pH is changed in the mimetic fluid of 20.
도 4는 pH=10의 모사체액에서 온도를 변화시킴에 따라 콜라겐 지지체 표면에 코팅된 아파타이트를 촬영한 SEM 사진이다.Figure 4 is a SEM photograph of the apatite coated on the surface of the collagen support as the temperature is changed in the simulated solution of pH = 10.
이하, 본 발명을 상세히 설명하기로 한다. 본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 아니 되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다.Hereinafter, the present invention will be described in detail. The terms or words used in this specification and claims are not to be construed as limiting in their usual or dictionary meanings, and the inventors may appropriately define the concept of terms in order to best explain their invention in the best way possible. It should be interpreted as meaning and concept corresponding to the technical idea of the present invention based on the principle that the present invention.
본 발명의 일구현예에 따른, 아파타이트가 코팅된 콜라겐 지지체의 제조방법은 염산염, 탄산염, 인산염 및 황산염 중 1종 이상의 염을 포함하는 모사체액을 준비하는 단계; 상기 모사체액의 pH를 8 내지 13으로 조절하는 단계; 및 콜라겐 지지체를 상기 모사체액에 침지하여 상기 지지체의 표면에 아파타이트를 코팅하는 단계;를 포함한다.According to one embodiment of the present invention, a method of preparing an apatite-coated collagen support includes preparing a mimetic fluid including at least one salt of hydrochloride, carbonate, phosphate and sulfate; Adjusting the pH of the mimetic solution to 8 to 13; And coating an apatite on the surface of the support by immersing the collagen support in the mimetic fluid.
상기 제조방법은 최적의 조건, 예를 들어 소정 pH 범위 및/또는 소정 온도범위를 갖는 모사체액을 사용하여 골의 무기 성분인 아파타이트를 콜라겐 지지체에 효율적으로 코팅시킬 수 있는 방법을 제공한다.The manufacturing method provides a method for efficiently coating the collagen support with the apatite, which is an inorganic component of bone, using a mimetic fluid having optimal conditions, for example, a predetermined pH range and / or a predetermined temperature range.
상기와 같이 모사체액의 pH가 변하는 경우 타겟인 콜라겐 지지체 표면에서 전하 분포가 달라지게 되고, 이와 같은 전하 분포의 변화는 상기 지지체 표면에서 양전하를 갖는 금속 이온의 농도를 변화시키게 되므로 금속 이온과 지지체와의 결합에 영향을 미치게 될 수 있다. 모사체액의 pH가 변함에 따라 콜라겐 지지체 표면 상에서 금속 이온의 분포화에 변화를 개괄적으로 보여주는 모식도를 도 1에 도시한다.As described above, when the pH of the mimetic fluid is changed, the charge distribution is changed on the target collagen support surface, and the change of the charge distribution changes the concentration of the positively charged metal ions on the support surface. This can affect the combination of. A schematic diagram schematically showing the change in the distribution of metal ions on the collagen support surface as the pH of the mimetic fluid changes is shown in FIG. 1.
본 발명의 콜라겐 지지체 제조방법은 다양한 염류가 용해된 모사체액의 pH를 콜라겐 지지체의 등전점인 8 이상으로 조절하는 단계를 필수적으로 포함하며, 도 1에 도시한 바와 같이 콜라겐의 등전점(PI)인 pH=8을 기준으로 모사체액의 pH가 등전점보다 낮은 pH 범위, 예를 들어 pH 6 이하에서는 콜라겐 표면이 양전하를 띄게 되어서 콜라겐 표면에 아파타이트의 주요 성분인 칼슘 이온이 흡착하기 어려워지게 된다. 따라서 아파타이트의 코팅 함량은 감소하게 된다.The method for preparing collagen support of the present invention essentially includes adjusting the pH of the simulated solution in which various salts are dissolved to 8 or more, which is the isoelectric point of the collagen support, and the pH of collagen isoelectric point (PI) as shown in FIG. 1. When the pH of the mimetic fluid is lower than the isoelectric point, for example, pH 6 or less, the surface of the collagen becomes positively charged, which makes it difficult to adsorb calcium ions, the main component of apatite, to the surface of the collagen. Thus, the coating content of apatite is reduced.
그러나 모사체액의 pH가 등전점인 pH=8 보다 높아지면 콜라겐 표면 전하가 음전하를 많이 띄기 때문에 양전하를 띄는 칼슘 이온 등의 금속 이온이 정전기적 인력에 의해 상대적으로 콜라겐에 잘 결합하게 된다. 따라서 모사체액의 pH가 8보다 높아질수록 콜라겐 표면에 아파타이트가 코팅되는 효율이 극대화될 수 있게 된다.However, when the pH of the mimetic fluid is higher than the isoelectric point, pH = 8, since the surface charge of the collagen has a lot of negative charges, metal ions such as calcium ions having positive charges bind relatively well to collagen due to electrostatic attraction. Therefore, as the pH of the mimetic fluid is higher than 8, the efficiency of apatite coating on the collagen surface can be maximized.
일구현예에 따르면, 상기 콜라겐 지지체로서는 콜라겐 스펀지(collagen sponge)를 사용할 수 있다. 이와 같은 콜라겐 스펀지로서는 콜라겐에 공동이나 공극을 가지는 구조체라면 특별히 제한 없이 사용할 수 있으며, 예를 들어 콜라겐 용액 또는 분산액을 동결건조 하여 제조한 것을 사용할 수 있다. 상기 동결건조 방법에 특별히 제한은 없다.According to one embodiment, a collagen sponge may be used as the collagen support. As such a collagen sponge, any structure having a cavity or void in collagen can be used without particular limitation. For example, a collagen solution or a dispersion prepared by lyophilization can be used. There is no particular limitation on the lyophilization method.
상기 콜라겐 지지체의 표면에 아파타이트 코팅을 실시할 때 상기 콜라겐은 모사체액에 용해되지 않는 것이 좋으므로, 필요시 가교시키거나 불용화할 필요가 있다. 예를 들어 상기 가교의 예로서 물리적 및/또는 화학적 가교를 이용할 수 있고, 이와 같은 물리적 가교 공정으로서는 UV 처리 등을 사용할 수 있으며, 상기 화학적 가교 공정으로서는 글루타르알데히드, 포르말린, 디알데히드 전분 등의 알데히드 화합물, 폴리에틸렌글리콜디글리시딜에테르 등의 수용성 폴리에폭시 화합물, 헥사메틸렌 디이소시아네이트 등의 이소시아네이트 화합물 등을 사용하는 가교 공정을 사용할 수 있다. 이와 같은 물리적 또는 화학적 가교 공정에서, 가교제 및 가교물은 세포 독성이 없고, 생체 친화성이 우수한 것을 사용할 수 있다.When the apatite coating is applied to the surface of the collagen support, it is preferable that the collagen is not dissolved in the mimetic fluid, so that it is necessary to crosslink or insolubilize if necessary. For example, physical and / or chemical crosslinking may be used as an example of the crosslinking, UV treatment or the like may be used as such a physical crosslinking process, and aldehydes such as glutaraldehyde, formalin, and dialdehyde starch may be used as the chemical crosslinking process. Crosslinking process using a compound, water-soluble polyepoxy compounds, such as polyethyleneglycol diglycidyl ether, and isocyanate compounds, such as hexamethylene diisocyanate, etc. can be used. In such a physical or chemical crosslinking process, the crosslinking agent and the crosslinked product may be one which is not cytotoxic and excellent in biocompatibility.
본 발명의 일구현예에 따르면, 콜라겐 지지체의 표면을 모사체액에 용해된 칼슘과 인이 주요 성분인 아파타이트로 코팅하게 된다. 상기 표면이란 콜라겐 지지체, 예를 들어 콜라겐 스펀지의 전체 및/또는 일부의 표면 외에, 상기 지지체에 존재하는 공동 및/또는 공극의 표면도 포함할 수 있다. 이때, 아파타이트가 표면 전부에 코팅되어도 좋고, 표면 일부에 부분적으로 코팅되어도 좋다. 코팅 수단은 특별히 한정되는 것이 아니나, 모사체액에 콜라겐 지지체를 침지하는 방법을 예시할 수 있다.According to one embodiment of the present invention, the surface of the collagen support is coated with apatite, the main component of calcium and phosphorus dissolved in the mimetic fluid. The surface may include the surface of the cavity and / or voids present in the support, in addition to the surface of the collagen support, eg, all and / or a portion of the collagen sponge. At this time, the apatite may be coated on the entire surface, or may be partially coated on the surface. Although a coating means is not specifically limited, The method of immersing a collagen support body in a mimic liquid can be illustrated.
일구현예에 따르면, 상기 모사체액은 물, 예를 들어 증류수 또는 탈이온수에 염류가 1종 이상 포함된 용액을 사용할 수 있으며, 이와 같은 염류로서는 염산염, 탄산염, 인산염 및 황산염 중 1종 이상을 사용할 수 있으며, 이들 염은 금속이온으로서 알칼리금속 및/또는 알칼리토금속을 포함할 수 있다. 상기 알칼리금속으로서는 나트륨, 칼륨 등을 예시할 수 있고, 상기 알칼리토금속으로는 마그네슘, 칼슘 등을 사용할 수 있다.According to one embodiment, the mimetic liquid may be a solution containing one or more salts in water, for example distilled water or deionized water, and one or more of hydrochloride, carbonate, phosphate and sulfate may be used as such salts. And, these salts may include alkali metals and / or alkaline earth metals as metal ions. Examples of the alkali metal include sodium, potassium, and the like, and magnesium, calcium, and the like may be used as the alkaline earth metal.
일구현예에 따르면, 상기 염산염은 알칼리 금속이나 알칼리 토금속이 염소와 결합한 화합물을 예시할 수 있으며, 예를 들어 NaCl, KCl, MgCl2, CaCl2 등을 사용할 수 있다.According to one embodiment, the hydrochloride may exemplify a compound in which an alkali metal or alkaline earth metal is combined with chlorine, and for example, NaCl, KCl, MgCl 2 , CaCl 2 , and the like may be used.
일구현예에 따르면, 상기 탄산염으로는 탄산(H2CO3)의 수소 모두가 알칼리 금속 또는 알칼리토금속으로 치환된 2차 탄산염, 또는 탄산의 수소 1개가 알칼리금속으로 치환된 1차 탄산염(중탄산염)을 사용할 수 있다.According to one embodiment, the carbonate is a secondary carbonate in which all of the hydrogen of carbonic acid (H 2 CO 3 ) is substituted with an alkali metal or alkaline earth metal, or a primary carbonate (bicarbonate) in which one hydrogen of carbonate is substituted with an alkali metal Can be used.
일구현예에 따르면, 상기 인산염으로는 인산(H3PO4)의 수소가 1개 치환된 1차 인산염 (인산이수소염), 인산의 수소가 2개 치환된 2차 인산염 (인산수소염), 인산의 수소가 3개 치환된 3차 인산염을 예시할 수 있으며, 이때 치환될 수 있는 금속으로는 알칼리 금속 또는 알칼리토금속을 예시할 수 있다. 이와 같은 인산염으로서는 K2HPO4, Na2HPO4, CaHPO4, MgHPO4, NaH2PO4, KH2PO4 등을 예시할 수 있다.According to one embodiment, the phosphate includes a primary phosphate (dihydrogen phosphate) in which one hydrogen of phosphoric acid (H 3 PO 4 ) is substituted, and a secondary phosphate (hydrogen phosphate) in which two hydrogens of phosphoric acid are substituted. For example, a tertiary phosphate in which hydrogen of phosphoric acid is three substituted may be exemplified, and examples of the metal which may be substituted may include an alkali metal or an alkaline earth metal. Examples of these phosphates and the like can be given K 2 HPO 4, Na 2 HPO 4, CaHPO 4, MgHPO 4, NaH 2 PO 4, KH 2 PO 4.
일구현예에 따르면, 상기 황산염으로는 황산(H2SO4)의 수소가 알칼리금속으로 1개 치환된 1차 황산염(중황산염), 황산의 수소가 모두 알칼리금속 또는 알칼리토금속으로 치환된 2차 황산염 등을 예시할 수 있으며, 예를 들어 Na2SO4, K2SO4, NaHSO4, KHSO4, MgSO4, CaSO4 등을 사용할 수 있다.According to one embodiment, the sulfate is a primary sulfate (bisulfate) in which hydrogen of sulfuric acid (H 2 SO 4 ) is substituted with an alkali metal, secondary hydrogen in which all of the hydrogen of the sulfuric acid is substituted with an alkali metal or alkaline earth metal sulfate and the like can be exemplified, for example, may be used, such as Na 2 SO 4, K 2 SO 4, NaHSO 4, KHSO 4, MgSO 4, CaSO 4.
일구현예에 따르면, 상기 모사체액은 염 성분으로 NaCl, NaHCO3, KCl, K2HPO4, MgCl2, CaCl2 및 Na2SO4 중 1종 이상을 포함할 수 있으며, 예를 들어 NaCl, NaHCO3, K2HPO4, 및 CaCl2 중 1종 이상을 포함할 수 있다.According to one embodiment, the mimetic fluid may include at least one of NaCl, NaHCO 3 , KCl, K 2 HPO 4 , MgCl 2 , CaCl 2 and Na 2 SO 4 as a salt component, for example NaCl, One or more of NaHCO 3 , K 2 HPO 4 , and CaCl 2 .
일구현예에 따르면, 이들 염성분은 물, 예를 들어 증류수 또는 탈이온수 등에 용해되어 사용되어 모사체액을 구성할 수 있으며, 이때 모사체액의 염 농도는 정상적인 건강체, 예를 들어 건강한 인체나 동물체의 체액 농도를 기준으로 1배 내지 20배, 예를 들어 1 배내지 15배, 혹은 1배 내지 10배의 범위를 가질 수 있다. 상기 모사체액의 농도가 높을수록 코팅되는 아파타이트의 코팅 함량이 증가하고, 코팅 시간 또한 감소할 수 있다.According to one embodiment, these salt components can be dissolved in water, for example distilled water or deionized water, and used to form a simulated body fluid, wherein the salt concentration of the simulated body fluid is of a normal healthy body, for example, a healthy human body or an animal body. It may have a range of 1 to 20 times, for example 1 to 15 times, or 1 to 10 times based on the body fluid concentration. As the concentration of the mimetic fluid is higher, the coating content of the coated apatite increases, and the coating time may also decrease.
일구현예에 따르면, 상술한 바와 같은 모사체엑에 콜라겐 지지체를 침지하여 아파타이트 성분을 상기 지지체의 표면 상에 코팅하게 되는 바, 이와 같은 코팅 단계에서 침지 공정은 1시간 이상, 예를 들어 5시간 이상, 또는 1일 이상 내지 10일 이하의 시간 동안 수행할 수 있으며, 이와 같은 침지 시간이 길면 길수록 다량의 아파타이트를 코팅할 수 있게 되지만, 침지시간이 지나치게 길어지면 콜라겐의 변성이 유발될 우려가 있다.According to one embodiment, the collagen support is immersed in the mimetic extract as described above to coat the apatite component on the surface of the support. In this coating step, the immersion process is performed for 1 hour or more, for example 5 hours. It can be carried out for more than one day, or more than one day to less than 10 days, the longer the immersion time is able to coat a large amount of apatite, but if the immersion time is too long there is a risk of collagen degeneration is caused. .
본 발명에서는 상기 모사체액의 pH 범위를 최적 범위, 예를 들어 pH = 8 내지 13으로 조절함으로써 동일한 모사체액의 농도에서 보다 짧은 시간 내에 충분한 함량의 아파타이트 코팅을 달성하게 된다. 이와 같은 단시간 내 코팅은 콜라겐 변성을 최소화할 수 있는 장점이 있다.In the present invention, by adjusting the pH range of the mimetic liquid to an optimum range, for example, pH = 8 to 13, a sufficient amount of apatite coating can be achieved in a shorter time at the same concentration of the mimetic liquid. Such a short time coating has an advantage of minimizing collagen denaturation.
일구현예에 따르면, 상기 아파타이트 코팅 함량은 상기 침지 공정이 수행되는 모사체액의 온도에 의해서도 달라질 수 있는 바, 콜라겐 지지체가 침지되는 모사체액의 온도는, 예를 들어 15 내지 35℃, 또는 15 내지 25℃의 범위를 사용할 수 있다. 상기 모사체액의 온도가 증가할수록 코팅시간을 단축시킬 수 있으나, 콜라겐의 변성이 유발될 우려가 있으므로 소정 범위로 조절하는 것이 바람직하다.According to one embodiment, the apatite coating content may vary depending on the temperature of the mimetic solution in which the immersion process is performed, and the temperature of the mimetic solution in which the collagen support is immersed is, for example, 15 to 35 ° C, or 15 to 15. A range of 25 ° C. can be used. The coating time can be shortened as the temperature of the mimetic fluid increases, but it is preferable to control the collagen in a predetermined range since there is a risk of degeneration of collagen.
본 발명에 따라 아파타이트, 예를 들어 히드록시아파타이트로 코팅처리된 콜라겐 지지체는 소정 pH 범위에서 단시간에 효율적으로 제조되어, 우수한 생체적합성, 세포적합성 및 골전도성(osteoconductivity) 등과 같은 골 재생효능을 갖도록 개질되어 의료용 이식재로서 유용하게 사용될 수 있다.Collagen support coated with apatite, for example, hydroxyapatite according to the present invention is efficiently prepared in a short time in a predetermined pH range, modified to have a bone regeneration effect such as excellent biocompatibility, cell compatibility and osteoconductivity (osteoconductivity) It can be usefully used as a medical implant.
이하, 본 발명을 구체적으로 설명하기 위해 실시예를 들어 상세하게 설명하기로 한다. 그러나, 본 발명에 따른 실시예는 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 아래에서 상술하는 실시예에 한정되는 것으로 해석되어서는 안 된다. 본 발명의 실시예는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해서 제공되는 것이다.Hereinafter, the present invention will be described in detail with reference to Examples. However, embodiments according to the present invention can be modified in many different forms, the scope of the present invention should not be construed as limited to the embodiments described below. The embodiments of the present invention are provided to more completely explain the present invention to those skilled in the art.
실시예 및 비교예Examples and Comparative Examples
소 유래의 콜라겐 타입 1로 이루어진 콜라겐 스펀지를 지지체로서 준비하였다.A collagen sponge composed of bovine-derived collagen type 1 was prepared as a support.
NaCl (8.0035 g/L), NaHCO3 (0.355 g/L), KCl (0.225 g/L), K2HPO42O (0.231 g/L), CaCl2 (0.292 g/L), Na2SO4 (0.072 g/L), 및 MgCl22O (0.311 g/L)을 증류수에 용해하여 모사체액을 제조하였다.NaCl (8.0035 g / L), NaHCO 3 (0.355 g / L), KCl (0.225 g / L), K 2 HPO 42 O (0.231 g / L), CaCl 2 (0.292 g / L), Na 2 SO 4 (0.072 g / L), and MgCl 22 O (0.311 g / L) were dissolved in distilled water to prepare a mimic liquid.
상기 모사체액에 NaOH 또는 HCl을 첨가하여 pH 범위를 pH 4, 5, 6, 7, 8, 9, 10, 11로 설정하였다. pH 4, 5, 6, 7은 비교예이고, pH 8, 9, 10, 11은 실시예이다.NaOH or HCl was added to the mimetic liquid The pH range was set to pH 4, 5, 6, 7, 8, 9, 10, 11. pH 4, 5, 6, 7 is a comparative example, and pH 8, 9, 10, 11 is an Example.
상기 모사체액 각각에 상기 콜라겐 지지체를 4℃, 20℃ 및 40℃의 서로 다른 온도 조건에서 24시간 동안 침지하여, 히드록시아파타이트가 표면에 코팅된 콜라겐 지지체를 얻었다. 비교를 위해 아무런 처리를 하지 않은 콜라겐 지지체를 준비하였다.The collagen support was immersed in each of the mimetic fluids at different temperature conditions of 4 ° C., 20 ° C. and 40 ° C. for 24 hours to obtain a collagen support coated with hydroxyapatite. The collagen support without any treatment was prepared for comparison.
실험예Experimental Example
4℃, 20℃ 및 40℃의 온도 조건에서 모사체액의 pH를 4부터 11까지 변화시켜 처리한 콜라겐 지지체의 히드록시아파타이트 코팅함량을 도 2에 나타내었다.The hydroxyapatite coating content of the collagen support treated by changing the pH of the mimetic fluid from 4 to 11 at 4 ° C., 20 ° C. and 40 ° C. temperature is shown in FIG. 2.
상기 코팅함량은 코팅 전후의 콜라겐 지지체의 함량변화를 측정한 후, 질량증가분 중 칼슘 분량을 계산하여 나타낸 값이다.The coating content is a value indicated by calculating the amount of calcium in the mass increase after measuring the change in the content of the collagen support before and after coating.
도 2에서 알 수 있는 바와 같이, 20℃ 및 pH 8 이상에서 지지체 표면에 코팅된 히드록시아파타이트의 코팅 함량이 가장 많음을 알 수 있다. 즉 20℃의 모사체액에서 가장 높은 코팅 함량을 보였으며, 4℃ 및 40℃ 모사체액을 사용한 경우보다 대략 20% 정도의 코팅 함량 증가를 나타내었다. 아울러 모사체액의 pH가 점점 높아질수록 콜라겐 지지체의 표면 전하가 더 강한 음전하를 띠게 되므로, 양전하를 띠는 칼슘 이온이 정전기적 인력에 의해 콜라겐 지지체 표면에 더욱 잘 결합하게 되는 것을 알 수 있다. 이와 같은 경향은 20℃의 모사 체액 온도에서 명확하게 알 수 있으며, 4℃에서도 이와 같은 경향은 유사하게 나타나지만 40℃에서는 이와 같은 경향이 다소 불명확함을 알 수 있다.As can be seen in Figure 2, it can be seen that the coating content of the hydroxyapatite coated on the surface of the support at 20 ℃ and pH 8 or more the most. That is, the highest coating content was found in the simulated body fluid at 20 ° C., and the coating content was increased by about 20% compared to the case where 4 ° C. and 40 ° C. body fluid were used. In addition, as the pH of the mimetic fluid increases, the surface charge of the collagen support becomes stronger and negatively charged. This tendency can be clearly seen at the simulated body fluid temperature of 20 ° C., and the trend is similar at 4 ° C., but it is clear that this trend is somewhat unclear at 40 ° C.
도 3은 20℃의 모사체액 조건에서 콜라겐 표면에 코팅된 히드록시아파타이트의 코팅 정도를 보여주는 SEM 이미지이다. SEM 사진으로부터 20℃의 모사체액을 사용하는 경우 pH가 증가할수록 콜라겐 지지체 표면에 코팅된 히드록시아파타이트의 함량이 대폭 증가하는 것을 확인할 수 있다. 도 4는 동일한 pH 값(pH=10)에서 4℃, 20℃ 및 40℃의 모사체액을 사용하는 경우의 코팅 정도를 나타내는 바, 20℃의 모사체액을 사용하는 경우 가장 높은 코팅 함량을 나타냄을 알 수 있다.FIG. 3 is an SEM image showing the degree of coating of hydroxyapatite coated on the collagen surface at 20 ° C. simulated liquid. When using the mimic body solution of 20 ℃ from the SEM picture it can be seen that the content of hydroxyapatite coated on the surface of the collagen support significantly increased. FIG. 4 shows the coating degree when using 4 ° C., 20 ° C. and 40 ° C. simulated liquid at the same pH value (pH = 10), and shows the highest coating content when using 20 ° C. simulated liquid. Able to know.
본 발명은 최적의 pH에서 골의 무기 성분인 아파타이트를 콜라겐 지지체에 효율적으로 코팅시킬 수 있는 방법을 제공한다. 상기 방법에 따르면, 보다 짧은 시간 내에 보다 많은 함량의 아파타이트를 콜라겐 지지체 상에 보다 간편하게 효율적으로 코팅하는 것이 가능해진다. 특히 상기 최적의 pH 범위 내에서, 소정 온도 범위를 갖는 모사체액을 사용하는 경우, 상기 아파타이트의 코팅 함량은 극대화될 수 있다.The present invention provides a method for efficiently coating the collagen support with an apatite, an inorganic component of bone at an optimal pH. According to this method, it becomes possible to coat more content of apatite on the collagen support more simply and efficiently within a shorter time. In particular, when using the mimetic liquid having a predetermined temperature range within the optimum pH range, the coating content of the apatite can be maximized.
상기 방법에 의해 얻어지는 골 재생용 지지체는 우수한 생체적합성과 골전도성을 나타내고, 골 재생을 촉진시키는 성장인자 단백질인 골형성 단백질(bone morphogenetic protein)을 서방형으로 방출시킬 수 있으므로, 골 관련 질환을 치료하기 위한 의료용 이식재 또는 골 재생용 골형성단백질의 전달체로 효과적으로 사용될 수 있게 된다.The support for bone regeneration obtained by the above method exhibits excellent biocompatibility and bone conductivity, and can release bone morphogenetic protein, a growth factor protein that promotes bone regeneration, in a sustained release manner, thereby treating bone-related diseases. It can be effectively used as a carrier for a medical implant or bone forming protein for bone regeneration.

Claims (8)

  1. 염산염, 탄산염, 인산염 및 황산염 중 1종 이상의 염을 포함하는 모사체액을 준비하는 단계;Preparing a mimetic fluid comprising at least one salt of hydrochloride, carbonate, phosphate and sulfate;
    상기 모사체액의 pH를 8 내지 13으로 조절하는 단계; 및Adjusting the pH of the mimetic solution to 8 to 13; And
    콜라겐 지지체를 상기 모사체액에 침지하여 상기 지지체의 표면에 아파타이트를 코팅하는 단계;를 포함하는 아파타이트가 코팅된 콜라겐 지지체의 제조방법.Coating an apatite on the surface of the support by immersing a collagen support in the mimetic fluid.
  2. 제1항에 있어서,The method of claim 1,
    상기 염이 NaCl, NaHCO3, KCl, K2HPO4, MgCl2, CaCl2, 및 Na2SO4 중 1종 이상인 것을 특징으로 하는 아파타이트가 코팅된 콜라겐 지지체의 제조방법.Method for producing an apatite-coated collagen support, characterized in that the salt is at least one of NaCl, NaHCO 3 , KCl, K 2 HPO 4 , MgCl 2 , CaCl 2 , and Na 2 SO 4 .
  3. 제1항에 있어서,The method of claim 1,
    상기 모사체액이 체액의 농도를 기준으로 1배 내지 20배의 농도를 갖는 것을 특징으로 하는 아파타이트가 코팅된 콜라겐 지지체의 제조방법.The method of producing apatite-coated collagen support, characterized in that the mimetic fluid has a concentration of 1 to 20 times the concentration of the body fluid.
  4. 제1항에 있어서,The method of claim 1,
    상기 모사체액의 pH가 8 내지 11인 것을 특징으로 하는 아파타이트가 코팅된 콜라겐 지지체의 제조방법.A method of producing an apatite-coated collagen support, characterized in that the pH of the mimetic solution is 8 to 11.
  5. 제1항에 있어서,The method of claim 1,
    상기 아파타이트가 히드록시아파타이트 인 것을 특징으로 하는 아파타이트가 코팅된 콜라겐 지지체의 제조방법.Method for producing an apatite-coated collagen support, characterized in that the apatite is hydroxyapatite.
  6. 제1항에 있어서,The method of claim 1,
    상기 콜라겐 지지체가 콜라겐 스펀지인 것을 특징으로 하는 아파타이트가 코팅된 콜라겐 지지체의 제조방법.Method for producing an apatite-coated collagen support, characterized in that the collagen support is a collagen sponge.
  7. 제1항에 있어서,The method of claim 1,
    상기 코팅 단계에서 상기 모사체액의 온도가 약 15 내지 약 35℃인 것을 특징으로 하는 아파타이트가 코팅된 콜라겐 지지체의 제조방법.The method of producing an apatite coated collagen support, characterized in that the temperature of the mimetic liquid in the coating step is about 15 to about 35 ℃.
  8. 제1항에 있어서,The method of claim 1,
    상기 코팅 단계에서 상기 모사체액의 온도가 약 15 내지 약 25℃인 것을 특징으로 하는 아파타이트가 코팅된 콜라겐 지지체의 제조방법.The apatite-coated collagen support, characterized in that the temperature of the mimetic liquid in the coating step is about 15 to about 25 ℃.
PCT/KR2014/000546 2013-01-22 2014-01-20 Method for producing collagen scaffold coated with apatite WO2014116000A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2013-0006958 2013-01-22
KR1020130006958A KR101449237B1 (en) 2013-01-22 2013-01-22 Method for preparing apatite-coated collagen scaffold

Publications (1)

Publication Number Publication Date
WO2014116000A1 true WO2014116000A1 (en) 2014-07-31

Family

ID=51227753

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2014/000546 WO2014116000A1 (en) 2013-01-22 2014-01-20 Method for producing collagen scaffold coated with apatite

Country Status (2)

Country Link
KR (1) KR101449237B1 (en)
WO (1) WO2014116000A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101643818B1 (en) 2014-10-10 2016-07-28 서울대학교산학협력단 Three-dimensional scaffolds of carbonized polyacrylonitrile promoting tissue regeneration and method of fabricating the same
KR101790782B1 (en) * 2015-06-18 2017-10-26 (주)다림티센 A bisphosphonates containing collagen based sustained delivery system for BMP and a method for manufacturing the same
KR102567367B1 (en) * 2021-02-24 2023-08-17 성균관대학교산학협력단 The manufacturing and implementation of microchanneled scaffold

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030099762A1 (en) * 2001-10-12 2003-05-29 Zongtao Zhang Coatings, coated articles and methods of manufacture thereof
KR20110040389A (en) * 2009-10-14 2011-04-20 서울대학교산학협력단 Preparation method of silk/hydroxyapatite hybrid nanofiber scaffold for bone regeneration
KR20120004739A (en) * 2010-07-07 2012-01-13 한국기계연구원 The coated scaffold for regeneration of hard tissue with components of bone matrix containing mesoporous bioactive glass by co-precipitation and the method thereof
KR20120036687A (en) * 2010-10-08 2012-04-18 단국대학교 산학협력단 Preparation method of microsphere carrier of calcium phosphate cement with collagen
KR20120092443A (en) * 2011-02-11 2012-08-21 서울대학교산학협력단 Surface-modified scaffold having improved bone regeneration ability and preparation thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030099762A1 (en) * 2001-10-12 2003-05-29 Zongtao Zhang Coatings, coated articles and methods of manufacture thereof
KR20110040389A (en) * 2009-10-14 2011-04-20 서울대학교산학협력단 Preparation method of silk/hydroxyapatite hybrid nanofiber scaffold for bone regeneration
KR20120004739A (en) * 2010-07-07 2012-01-13 한국기계연구원 The coated scaffold for regeneration of hard tissue with components of bone matrix containing mesoporous bioactive glass by co-precipitation and the method thereof
KR20120036687A (en) * 2010-10-08 2012-04-18 단국대학교 산학협력단 Preparation method of microsphere carrier of calcium phosphate cement with collagen
KR20120092443A (en) * 2011-02-11 2012-08-21 서울대학교산학협력단 Surface-modified scaffold having improved bone regeneration ability and preparation thereof

Also Published As

Publication number Publication date
KR101449237B1 (en) 2014-10-08
KR20140094305A (en) 2014-07-30

Similar Documents

Publication Publication Date Title
Wang et al. Amorphous polyphosphate, a smart bioinspired nano-/bio-material for bone and cartilage regeneration: towards a new paradigm in tissue engineering
Yavari et al. Bone regeneration performance of surface-treated porous titanium
Kokubo Formation of biologically active bone-like apatite on metals and polymers by a biomimetic process
CN105327396B (en) A kind of surface modifying method of orthopaedics implantation class medical equipment
Kim Ceramic bioactivity and related biomimetic strategy
Wu et al. Mineralized hydrogels induce bone regeneration in critical size cranial defects
Müller et al. Polyphosphate: a morphogenetically active implant material serving as metabolic fuel for bone regeneration
US20170100508A1 (en) Bio-artificial periosteum based on micropatterning of biomimetic mineralized calcium-phosphorus nanoparticles and method for manufacturing the same
EP1385449A2 (en) Biologically-functionalised, metabolically-inductive implant surfaces
WO2014116000A1 (en) Method for producing collagen scaffold coated with apatite
WO2016179089A1 (en) Biomimetic nano-composite scaffold for enhanced bone healing and fracture repair
KR20080078449A (en) Method for manufacturing bioactive apatite
Kokubo et al. Growth of novel ceramic layers on metals via chemical and heat treatments for inducing various biological functions
Saska et al. Biopolymer-based membranes associated with osteogenic growth peptide for guided bone regeneration
CN104119551B (en) Calcium strontium/gelatin bionic coating modifies the preparation method of artificial ligament
KR20140121804A (en) Method for preparing apatite-coated collagen scaffold
Pang et al. In vitro and in vivo evaluation of biomimetic hydroxyapatite/whitlockite inorganic scaffolds for bone tissue regeneration
Katsanevakis et al. Biomineralization of polymer scaffolds
Wei et al. Cuttlebone‐Derived Organic Matrix: A Facile Periosteum Substitute for Bone Regeneration
Stancu et al. The in vivo calcification capacity of a copolymer, based on methacryloyloxyethyl phosphate, does not favor osteoconduction
CA2704673A1 (en) Ceramic/structural protein composites and method of preparation thereof
US20210369462A1 (en) Methods for Carbonate Surface Coating and Related Bone Void Filler Compositions
Elghazel et al. TCP-fluorapatite composite scaffolds: mechanical characterization and in vitro/in vivo testing
KR101769019B1 (en) Guided bone regeneration composition, guided bone regeneration membrane and method for manufacturing the same
Douglas et al. Biomimetic mineralization of hydrogel biomaterials for bone tissue engineering

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14742898

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14742898

Country of ref document: EP

Kind code of ref document: A1